TCL Archive Four More Cooperative Groups Disapproved As NCI to Consider New Directions in Clinical Trials March 28, 1986
TCL Archive In Brief: House Fills Subcommittee Positions; Senate Schedules NCI Appropriations Hearing Feb. 18 February 13, 1981
TCL Archive In Brief: House Cuts NCI Rescission To $7.73 Million; Weinhuse, Ultmann New ACCR, ASCO Presidents May 8, 1981
TCL Archive Abraxane-Gemcitabine Combination Extends Overall Survival in Phase III Trial January 31, 2014
TCL Archive Senate Committee Approves Additional $400 Million For NCI, $275 Million For FDA. May 16, 2008